Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:717-722
Published online before print February 3, 2005, doi: 10.1161/01.ATV.0000157979.51673.2c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/4/717    most recent
01.ATV.0000157979.51673.2cv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Tits, L.
Right arrow Articles by Stalenhoef, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Tits, L.
Right arrow Articles by Stalenhoef, A.
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:717.)
© 2005 American Heart Association, Inc.


Vascular Biology

C-Reactive Protein and Annexin A5 Bind to Distinct Sites of Negatively Charged Phospholipids Present in Oxidized Low-Density Lipoprotein

Lambertus van Tits; Jacqueline de Graaf; Helga Toenhake; Waander van Heerde; Anton Stalenhoef

From the Department of Medicine (L.v.T., J.d.G., H.T., A.S.), Division of General Internal Medicine and Central Hematology Laboratory (W.v.H.), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Correspondence to L.J.H. van Tits, Department of Medicine, Division of General Internal Medicine 564, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 8, 6525 GA, Nijmegen, PO Box 9101, 6500 HB, Nijmegen, the Netherlands. E-mail B.vantits{at}aig.umcn.nl

Objective— To investigate binding of C-reactive protein (CRP) and annexin A5, 2 proteins with high affinity for negatively charged phospholipids, to oxidized low-density lipoprotein (LDL) and the consequences of these interactions for subsequent binding of oxidized LDL to monocyte/macrophage-like U937 cells.

Methods and Results— We found that CRP and annexin A5 at physiological concentrations bind Ca++ dependently to oxidized phosphatidylcholine present in oxidized LDL but not to native LDL. Binding of CRP to oxidized LDL did not interfere with binding of annexin A5, and vice versa. In the presence of 2 to 10 mg/L CRP, binding of 125I-labeled oxidized LDL to undifferentiated U937 cells increased 50% to 100%. This effect was independent of the presence of complement and could be inhibited by irrelevant IgG and by antibodies to CD64 but not by annexin A5. Annexin A5 alone had no effect on binding of oxidized LDL to the cells.

Conclusions— These findings suggest that: (1) CRP and annexin A5 at physiological concentrations bind to distinct sites of negatively charged phospholipids present in oxidized LDL; (2) CRP enhances binding of oxidized LDL to monocytic/macrophage-like cells via Fc{gamma} receptors; and (3) annexin A5 does not antagonize the CRP-induced enhanced binding of oxidized LDL to U937 cells.

We investigated interactions of C-reactive protein (CRP), annexin A5, and low-density lipoprotein (LDL) with U937 cells. CRP binds to oxidized LDL, and via subsequent interaction with Fc{gamma} receptors it enhances binding of the particle to U937 cells. Annexin A5 also binds to oxidized LDL but does not interfere with CRP.


Key Words: annexin • binding • C-reactive protein • Fc{gamma} receptors • oxidized LDL




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
U. Singh, M. R. Dasu, P. G. Yancey, A. Afify, S. Devaraj, and I. Jialal
Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats
J. Lipid Res., May 1, 2008; 49(5): 1015 - 1023.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Singh, M. V. Suresh, D. C. Prayther, J. P. Moorman, A. E. Rusinol, and A. Agrawal
C-Reactive Protein-Bound Enzymatically Modified Low-Density Lipoprotein Does Not Transform Macrophages into Foam Cells
J. Immunol., March 15, 2008; 180(6): 4316 - 4322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Dahl, J. Vestbo, P. Lange, S. E. Bojesen, A. Tybjaerg-Hansen, and B. G. Nordestgaard
C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 250 - 255.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, I. Jialal, B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, and I. Jialal
The Verdict Is Still Out
Circulation, May 2, 2006; 113(17): 2128 - 2151.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Montero, J. Orbe, N. Varo, O. Beloqui, J. I. Monreal, J. A. Rodriguez, J. Diez, P. Libby, and J. A. Paramo
C-Reactive Protein Induces Matrix Metalloproteinase-1 and -10 in Human Endothelial Cells: Implications for Clinical and Subclinical Atherosclerosis
J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1369 - 1378.
[Abstract] [Full Text] [PDF]